Score Your Stock

METRO METRO HEALTHCARE BERHAD

0329.KL · Health Care · Health Care Providers
Top 44% of scored stocks
Compare with nearby peers
OkayTop 44% of scored stocks
ShariahWeak SpotLimited Data

METRO scores 53/100 on fundamentals: in the top 44% of 1120 scored Bursa Malaysia stocks. Its strongest area is Financial Safety (100/100); its weakest is Price Fairness (0/100). It carries 2 warning flags: Weak Spot, Limited Data.

Best
Financial 100
Weakest
Price 0
  • Carries a Weak Spot flag
  • Carries a Limited Data flag
Mkt capRM 215.4m#512 of 1113 in BursaEPSRM 0.01P/E32×✗ vs sector avg 26×P/B2.9×✗ vs sector avg 1.7×Div yield2%✓ Top 35% in Bursa52w range · 44% of range0.200.24
as of 18 Oct 2026

Nearby peers

Ranks #13 of 30 in Health Care by score

#1DPHARMA85#11TMCLIFE57#12KOTRA53
#13METRO53
#14SUNMED51#15OPTIMAX50

One-Minute Summary

Why METRO scores 53

A financially strong, expensively priced stock, but price fairness needs attention.

What looks good
What to watch

After Jun '26 results: 47 → 49+2· Dividend Quality Weak → OkaySee all movers →

Business Strength

50
Why 50?
Pillar score: (1 + 1 + 1 + 1) = 4 of 8 points → 50 · 1 N/A skipped
Return on Equity (ROE)9%Okay4-Year Revenue Growth+5%/yrOkay4-Year Profit Growth+4%/yrOkayNet Profit Margin13%OkayQuarterly MomentumNo dataN/A
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↑ +11.3%Equity ↑ +101.1%ROE % 9.2%
Net ProfitEquityROE %
6m5m6m7m37m76m75m75m202320242025TTM16.6%6.1%7.9%9.2%

Revenue & Net Profit, with Net Margin

Revenue ↑ +14.3%Net Profit ↑ +11.3%Net Margin % 13.5%
RevenueNet ProfitNet Margin %
45m49m50m51m6m5m6m7m202320242025TTM13.9%9.5%11.7%13.5%

Sales grew about 14.3% over 4 years: customers keep spending more with this company.

Profit climbed about 11.3% over 4 years: the business keeps more money as it grows.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +4.8%Net Profit ↑ +25%Net Margin % 11.4%
RevenueNet ProfitNet Margin %
13m13m14m11m13m1m2m2m1m2mJun '25Sep '25Dec '25Mar '26Jun '269.5%15.3%16.3%8.9%11.4%
▲

Sales have stayed roughly flat over the last 5 quarters.

Profit grew about 25% over the last 5 quarters: the business is keeping more of what it earns.

Why 100?
Pillar score: (2 + 2 + 2) = 6 of 6 points → 100
Debt-to-Equity0.2×StrongCurrent Ratio8.6×StrongInterest Coverage14.8×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt → -0.6%Equity ↑ +101.1%D/E 0.2×
Total DebtEquityD/E
18m16m14m18m37m76m75m75m202320242025TTM0.5×0.2×0.2×0.2×

Borrowings have stayed roughly level: manageable, as long as profits stay healthy.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +167.1%Current Liabilities ↑ +20.7%Current Ratio 8.6×
Current AssetsCurrent LiabilitiesCurrent Ratio
23m60m60m60m6m6m5m7m202320242025TTM3.9×10.5×12×8.6×
Why 63?
Pillar score: (0 + 1 + 2 + 2) = 5 of 8 points → 63
Dividend Quality2%Weak
Payout ratio: 71%
Operating Cash FlowPositive but bumpyOkayFree Cash FlowPositive & growingStrongCash & Cash EquivalentsGrowing & covers near-term debtStrong
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↓ -3.7%Free CF ↓ -4.1%
Operating CFFree CF
11m10m9m11m7m6m8m7m202320242025TTM

Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.

Cash vs Total Debt

Cash ↑ +214.5%Total Debt → -0.6%
CashTotal Debt
15m51m51m48m18m16m14m18m202320242025TTM

Dividends per Share, with Yield

DPS (sen) ↑ +30%Yield % 2.3%
DPS (sen)Yield %
0.50.50.50.720222023202420250.8%0.9%1%2.3%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 0?
Pillar score: (0 + 0 + 0) = 0 of 6 points → 0
P/E Ratio32×WeakP/B Ratio2.9×WeakPEG Ratio10.2Weak
Show chart

Score vs Share Price

Score (0-100)Share price
RM 0.24RM 0.22RM 0.20100500Oct '25Feb '26Jun '26Oct '26💰📊

The share price is down about 5.2% over the past year.

What happened, and how the price moved

Why 50?
Pillar score: (2 + 1 + 1 + 1 + 0) = 5 of 10 points → 50 · 1 N/A skipped
Earnings ConsistencySteadyStrongDebt Trend (4yr)StableOkayShare Count Trend (4yr)+6%/yrOkayInventory vs Sales (4yr)+6.2 pp/yr vs salesOkayAsset Turnover Trend (4yr)-30.3%WeakQuarterly ConsistencyNo dataN/A
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +14.3%Inventory ↑ +36.8%Inv. % of Rev. 5.1%
RevenueInventoryInv. % of Rev.
45m49m50m51m2m2m3m3m202320242025TTM4.3%4.9%5.6%5.1%

Get an email when METRO's score changes, and why

Own more than one stock? Check them all at once ›
Ranks #13 of 30 in Health Care by score

Sector peers

#1DPHARMA85#11TMCLIFE57#12KOTRA53
#13METRO (you)53
#14SUNMED51#15OPTIMAX50

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDividend Payout RatioDiv yieldP/E RatioP/B RatioPEG Ratio
2026RM 51.1mRM 6.9mRM 10.5mRM 7.1mRM -3.5mRM 47.8mRM 17.7mRM 1.9mRM 75.2mRM 60.1mRM 7.0mRM 98.1mRM 22.9mRM 2.6m-9%13%0.2×8.6×14.8×71%----
2025RM 50.4mRM 5.9mRM 9.1mRM 7.6mRM -1.5mRM 50.6mRM 14.3m-RM 75.1mRM 59.8mRM 5.0mRM 92.5mRM 17.4mRM 2.8mRM 0.7m8%12%0.2×11.9×14.2×109%3%36.2×2.8×6.8
2024RM 48.6mRM 4.6mRM 10.0mRM 5.6mRM -4.4mRM 51.4mRM 16.0m-RM 75.6mRM 59.9mRM 5.7mRM 96.0mRM 20.4mRM 2.4mRM 0.5m6%9%0.2×10.5×11.3×97%2%47.2×2.9×-
2023RM 44.7mRM 6.2mRM 10.9mRM 7.4mRM -3.6mRM 15.2mRM 17.8m-RM 37.4mRM 22.5mRM 5.8mRM 59.8mRM 22.4mRM 1.9mRM 0.5m17%14%0.5×3.9×12.7×69%1%78.7×13.2×3.2